Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Floyd

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Tropical Medicine & International Health : TM & IH|September 10, 2020
National tuberculosis prevalence surveys in Africa, 2008-2016: an overview of results and lessons learnedIrwin Law, Katherine Floyd,
The Lancet. Infectious Diseases|December 22, 2016
Resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones - Authors' replyMatteo Zignol, Katherine Floyd
Pharmacoeconomics|November 11, 2011
A systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosisChristopher Fitzpatrick, Katherine Floyd
Bulletin of the World Health Organization|August 2, 2008
Financial resources required for tuberculosis control to achieve global targets set for 2015Katherine Floyd, Andrea Pantoja
Clinics in Chest Medicine|November 21, 2009
Global burden and epidemiology of tuberculosisPhilippe Glaziou, Katherine Floyd, Mario Raviglione
Bulletin of the World Health Organization|July 20, 2007
Financing tuberculosis control: the role of a global financial monitoring systemKatherine Floyd, Andrea Pantoja, Christopher Dye
Thorax|April 21, 2018
Trends in tuberculosis in the UKPhilippe Glaziou, Katherine Floyd, Mario Raviglione
BMJ (Clinical Research Ed.)|November 12, 2005
Cost effectiveness analysis of strategies for tuberculosis control in developing countriesRob Baltussen, Katherine Floyd, Christopher Dye
Lancet (London, England)|July 9, 2013
Moving the goalposts for tuberculosis targets in AfricaKatherine Floyd, Philippe Glaziou, Mario Raviglione
Seminars in Respiratory and Critical Care Medicine|August 3, 2018
Global Epidemiology of TuberculosisPhilippe Glaziou, Katherine Floyd, Mario C Raviglione
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Tropical Medicine & International Health : TM & IH|September 10, 2020
National tuberculosis prevalence surveys in Africa, 2008-2016: an overview of results and lessons learnedIrwin Law, Katherine Floyd,
The Lancet. Infectious Diseases|December 22, 2016
Resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones - Authors' replyMatteo Zignol, Katherine Floyd
Pharmacoeconomics|November 11, 2011
A systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosisChristopher Fitzpatrick, Katherine Floyd
Bulletin of the World Health Organization|August 2, 2008
Financial resources required for tuberculosis control to achieve global targets set for 2015Katherine Floyd, Andrea Pantoja
Clinics in Chest Medicine|November 21, 2009
Global burden and epidemiology of tuberculosisPhilippe Glaziou, Katherine Floyd, Mario Raviglione
Bulletin of the World Health Organization|July 20, 2007
Financing tuberculosis control: the role of a global financial monitoring systemKatherine Floyd, Andrea Pantoja, Christopher Dye
Thorax|April 21, 2018
Trends in tuberculosis in the UKPhilippe Glaziou, Katherine Floyd, Mario Raviglione
BMJ (Clinical Research Ed.)|November 12, 2005
Cost effectiveness analysis of strategies for tuberculosis control in developing countriesRob Baltussen, Katherine Floyd, Christopher Dye
Lancet (London, England)|July 9, 2013
Moving the goalposts for tuberculosis targets in AfricaKatherine Floyd, Philippe Glaziou, Mario Raviglione
Seminars in Respiratory and Critical Care Medicine|August 3, 2018
Global Epidemiology of TuberculosisPhilippe Glaziou, Katherine Floyd, Mario C Raviglione
Pageof 8